The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival
<i>Objectives</i>: This study aimed to evaluate the prognostic significance and relationship of miR-497 and metadherin to hepatocellular carcinoma (HCC) tumor characteristics and patients’ survival. <i>Methods</i>: This study enrolled 120 (60 HCC patients and 60 healthy) subj...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/9/866 |
id |
doaj-99252db94c2c4203a337d15fffda582e |
---|---|
record_format |
Article |
spelling |
doaj-99252db94c2c4203a337d15fffda582e2021-09-26T00:39:05ZengMDPI AGMedicina1010-660X1648-91442021-08-015786686610.3390/medicina57090866The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ SurvivalDina A. Ali0Nesreen M. Sabry1Ahmed M. Kabel2Rasha A. Gaber3Hwaida M. Mokhtar4Sara M. Samy5Mohamed A. Elrashidy6Samir A. Salama7Dina Abdelhai8Clinical Pathology Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptClinical Oncology Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptPharmacology Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptMedical Biochemistry Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptRadiodiagnosis Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptMicrobiology and Immunology Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptPathology Department, Faculty of Medicine, Tanta University, Tanta 31527, EgyptDivision of Biochemistry, Department of Pharmacology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi ArabiaClinical Pathology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt<i>Objectives</i>: This study aimed to evaluate the prognostic significance and relationship of miR-497 and metadherin to hepatocellular carcinoma (HCC) tumor characteristics and patients’ survival. <i>Methods</i>: This study enrolled 120 (60 HCC patients and 60 healthy) subjects. Serum miR-497 and metadherin mRNA relative expression were analyzed by real-time quantitative reverse transcription polymerase chain reaction. The overall survival (OS) of HCC patients was assessed using the Kaplan–Meier curve and log-rank test. <i>Results</i>: Serum miR-497 showed statistically significant downregulation in HCC patients compared to controls (<i>p</i> < 0.001). Serum metadherin mRNA relative expression was significantly upregulated in HCC patients compared to controls (<i>p</i> < 0.001). Both serum miR-497 and metadherin mRNA expression were significantly associated with the number of tumor foci (<i>p</i> = 0.028 and 0.001, respectively), tumor size (<i>p</i> = 0.022 and <0.001, respectively), nodal metastasis (<i>p</i> = 0.003 and 0.003, respectively), distant metastasis (<i>p</i> = 0.003 and 0.003, respectively), vascular invasion (<i>p</i> = 0.040 and <0.001, respectively), and BCLC staging (<i>p</i> = 0.043 and 0.004, respectively). The overall survival was lower in patients with low miR-497 expression (<i>p</i> = 0.046) and in patients with high metadherin expression (<i>p</i> < 0.001). <i>Conclusions</i>: The expression levels of miR-497 showed downregulation in HCC patients, but metadherin expression showed upregulation. Both markers were inversely related and closely correlated with tumor characteristics and patients’ survival.https://www.mdpi.com/1648-9144/57/9/866hepatocellular carcinomamiRNA-497metadherinprognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dina A. Ali Nesreen M. Sabry Ahmed M. Kabel Rasha A. Gaber Hwaida M. Mokhtar Sara M. Samy Mohamed A. Elrashidy Samir A. Salama Dina Abdelhai |
spellingShingle |
Dina A. Ali Nesreen M. Sabry Ahmed M. Kabel Rasha A. Gaber Hwaida M. Mokhtar Sara M. Samy Mohamed A. Elrashidy Samir A. Salama Dina Abdelhai The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival Medicina hepatocellular carcinoma miRNA-497 metadherin prognosis |
author_facet |
Dina A. Ali Nesreen M. Sabry Ahmed M. Kabel Rasha A. Gaber Hwaida M. Mokhtar Sara M. Samy Mohamed A. Elrashidy Samir A. Salama Dina Abdelhai |
author_sort |
Dina A. Ali |
title |
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival |
title_short |
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival |
title_full |
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival |
title_fullStr |
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival |
title_full_unstemmed |
The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival |
title_sort |
expression of circulating mir-497 and metadherin in hepatocellular carcinoma: relation to the tumor characteristics and patients’ survival |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X 1648-9144 |
publishDate |
2021-08-01 |
description |
<i>Objectives</i>: This study aimed to evaluate the prognostic significance and relationship of miR-497 and metadherin to hepatocellular carcinoma (HCC) tumor characteristics and patients’ survival. <i>Methods</i>: This study enrolled 120 (60 HCC patients and 60 healthy) subjects. Serum miR-497 and metadherin mRNA relative expression were analyzed by real-time quantitative reverse transcription polymerase chain reaction. The overall survival (OS) of HCC patients was assessed using the Kaplan–Meier curve and log-rank test. <i>Results</i>: Serum miR-497 showed statistically significant downregulation in HCC patients compared to controls (<i>p</i> < 0.001). Serum metadherin mRNA relative expression was significantly upregulated in HCC patients compared to controls (<i>p</i> < 0.001). Both serum miR-497 and metadherin mRNA expression were significantly associated with the number of tumor foci (<i>p</i> = 0.028 and 0.001, respectively), tumor size (<i>p</i> = 0.022 and <0.001, respectively), nodal metastasis (<i>p</i> = 0.003 and 0.003, respectively), distant metastasis (<i>p</i> = 0.003 and 0.003, respectively), vascular invasion (<i>p</i> = 0.040 and <0.001, respectively), and BCLC staging (<i>p</i> = 0.043 and 0.004, respectively). The overall survival was lower in patients with low miR-497 expression (<i>p</i> = 0.046) and in patients with high metadherin expression (<i>p</i> < 0.001). <i>Conclusions</i>: The expression levels of miR-497 showed downregulation in HCC patients, but metadherin expression showed upregulation. Both markers were inversely related and closely correlated with tumor characteristics and patients’ survival. |
topic |
hepatocellular carcinoma miRNA-497 metadherin prognosis |
url |
https://www.mdpi.com/1648-9144/57/9/866 |
work_keys_str_mv |
AT dinaaali theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT nesreenmsabry theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT ahmedmkabel theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT rashaagaber theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT hwaidammokhtar theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT saramsamy theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT mohamedaelrashidy theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT samirasalama theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT dinaabdelhai theexpressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT dinaaali expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT nesreenmsabry expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT ahmedmkabel expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT rashaagaber expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT hwaidammokhtar expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT saramsamy expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT mohamedaelrashidy expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT samirasalama expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival AT dinaabdelhai expressionofcirculatingmir497andmetadherininhepatocellularcarcinomarelationtothetumorcharacteristicsandpatientssurvival |
_version_ |
1716870186362994688 |